Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 8/20 | 0.36 |
| ▸ | CALCR | P30988 | 3/20 | 0.34 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.34 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.34 |
| ▸ | APLNR | P35414 | 1/20 | 0.34 |
| ▸ | GLP1R | P43220 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Arginine SCHEMBL6481630 | 0.96 | GLP1R (0.35) | VIPR2VIPR1GLP1R | |
| Arginine SCHEMBL27629650 | 0.94 | GLP1R (0.34) | GLP1R | |
| Arginine SCHEMBL27640159 | 0.92 | GLP1R (0.33) | GLP1R | |
| Arginine SCHEMBL27495388 | 0.91 | PTH1R (0.38) | PTH1RVIPR2VIPR1APLNRGLP1R | |
| Cystine SCHEMBL27709554 | 0.89 | GLP1R (0.32) | GLP1R | |
| Cystine SCHEMBL9697229 | 0.88 | CALCR (0.37) | PTH1RCALCRAPLNRKEAP1 | |
| Arginine SCHEMBL28484320 | 0.88 | VIPR2 (0.36) | VIPR2VIPR1GLP1R | |
| D-Histidine SCHEMBL27900898 | 0.88 | BACE1 (0.33) | CALCR | |
| Arginine SCHEMBL28894222 | 0.87 | APLNR (0.36) | PTH1RCALCRAPLNRGLP1R | |
| Arginine SCHEMBL28894087 | 0.87 | APLNR (0.36) | PTH1RCALCRAPLNRGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1678755-A | Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors | VIROLOGIC INC (US) | 2005-10-05 | — | — | CN | disclosed |